Proton beam therapy combined with retrograde intra-arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report.

AC IAIC PBT chemoradiotherapy head and neck cancer radiotherapy

Journal

Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 09 07 2019
accepted: 01 07 2020
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 18 8 2020
Statut: ppublish

Résumé

Ameloblastic carcinoma (AC) is a very rare malignant odontogenic tumor. Although surgical resection is generally performed, treatment approaches have not been established for recurrent cases. Chemotherapy and radiotherapy are positioned as adjunctive therapies, and few studies investigated definitive non-operative therapy. We present the case of a 71-year-old male with recurrent secondary-type AC arising from the right maxilla, who was treated with proton beam therapy (PBT; 71.4 Gy relative biological effectiveness in 32 fractions) combined with continuous intra-arterial infusion of cisplatin (40 mg/m

Identifiants

pubmed: 32802330
doi: 10.3892/mco.2020.2104
pii: MCO-0-0-02104
pmc: PMC7412713
doi:

Types de publication

Journal Article

Langues

eng

Pagination

34

Informations de copyright

Copyright: © Takayama et al.

Références

Int J Oral Maxillofac Surg. 2013 Aug;42(8):934-8
pubmed: 23726272
J Neuroophthalmol. 2010 Dec;30(4):315-20
pubmed: 20736842
J Korean Assoc Oral Maxillofac Surg. 2016 Feb;42(1):43-6
pubmed: 26904494
Strahlenther Onkol. 2014 Feb;190(2):186-91
pubmed: 24362502
Clin Oncol (R Coll Radiol). 2003 Dec;15(8):467-72
pubmed: 14690002
Head Neck. 1998 Oct;20(7):654-9
pubmed: 9744469
Cancers (Basel). 2018 Sep 15;10(9):
pubmed: 30223580
BMC Ophthalmol. 2007 Apr 05;7:6
pubmed: 17411428
J Pharm Bioallied Sci. 2014 Jul;6(Suppl 1):S208-11
pubmed: 25210376
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Feb;127(2):e56-e60
pubmed: 30393089
Med Phys. 1986 Sep-Oct;13(5):734-41
pubmed: 3023803
Oncol Lett. 2015 Jan;9(1):459-467
pubmed: 25436009
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1033-9
pubmed: 19356861
Radiat Oncol. 2014 Jul 15;9:157
pubmed: 25027948
J Clin Oncol. 1994 Oct;12(10):2113-20
pubmed: 7931481
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Dec;108(6):904-13
pubmed: 19800270
Radiother Oncol. 2014 May;111(2):306-10
pubmed: 24746571
Oral Oncol. 2018 Feb;77:118-124
pubmed: 29362117
Cancer. 1984 Feb 15;53(4):869-73
pubmed: 6420036
J Oral Maxillofac Surg. 2019 Jan;77(1):227.e1-227.e5
pubmed: 30240599
Cancer. 2000 Nov 15;89(10):2099-105
pubmed: 11066051
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):e17-24
pubmed: 17942338
Biochim Biophys Acta. 2009 Dec;1796(2):216-29
pubmed: 19682551
Head Neck. 2012 Nov;34(11):1634-9
pubmed: 22179897
Am J Otolaryngol. 2003 Jan-Feb;24(1):64-9
pubmed: 12579485
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun;105(6):783-9
pubmed: 18206406
J Craniomaxillofac Surg. 1998 Jun;26(3):159-62
pubmed: 9702634
Radiat Oncol. 2011 Feb 06;6:13
pubmed: 21294917
Lancet Oncol. 2014 Aug;15(9):1027-38
pubmed: 24980873
Head Neck. 2016 Apr;38 Suppl 1:E2151-8
pubmed: 25735803
Laryngoscope. 2004 Oct;114(10):1770-4
pubmed: 15454770

Auteurs

Kanako Takayama (K)

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Fukushima 963-8052, Japan.
Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.

Tatsuya Nakamura (T)

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Fukushima 963-8052, Japan.

Akinori Takada (A)

Department of Radiology, Mie University Hospital, Tsu, Mie 514-8507, Japan.

Takahiro Kato (T)

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Fukushima 963-8052, Japan.

Hideo Sakuma (H)

Department of Pathology, Southern Tohoku General Hospital, Koriyama, Fukushima 963-8563, Japan.

Kenji Mitsudo (K)

Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.

Nobukazu Fuwa (N)

Department of Radiation Oncology, Ise Red Cross Hospital, Ise, Mie 516-0008, Japan.

Masao Murakami (M)

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Fukushima 963-8052, Japan.

Classifications MeSH